Jorge S. Reis‐Filho
AstraZeneca (United Kingdom)(GB)Memorial Sloan Kettering Cancer Center(US)AstraZeneca (Netherlands)(NL)AstraZeneca (Singapore)(SG)AstraZeneca (Brazil)(BR)AstraZeneca (Japan)(JP)AstraZeneca (Finland)(FI)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, BRCA gene mutations in cancer
Most-Cited Works
- → Triple-Negative Breast Cancer(2010)4,107 cited
- → The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014(2014)3,065 cited
- → The landscape of cancer genes and mutational processes in breast cancer(2012)1,717 cited
- → Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF(2010)1,455 cited
- → Basal-Like Breast Cancer: A Critical Review(2008)1,160 cited
- → Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer(2015)1,115 cited